Literature DB >> 2631202

Coronary risk factor and lifestyle variation across Scotland: results from the Scottish Heart Health Study.

H Tunstall-Pedoe1, W C Smith, I K Crombie, R Tavendale.   

Abstract

Between 1984 and 1986 the Scottish Heart Health Study recorded coronary risk factors and lifestyle in 10,359 men and women aged 40-59 years across 22 districts of Scotland--districts whose standardised mortality ratio for coronary heart disease in men varied from 61 in Eastwood to 136 in Monklands. This paper presents the results by district. Cigarette smoking levels showed the greatest variation, from 29% to 52% in men and 24% to 51% in women. Blood pressure means varied but were not high (129-138mmHg systolic in men, 126-137mmHg in women, 81-88mmHg diastolic in men and 77-84mmHg in women). Mean serum cholesterol values were high and varied little by district in men, (6.1 to 6.5mmol/l), although there was more variation in women (6.3 to 7.0mmol/l). Body mass index (25.3 to 26.6kg/m2 in men and 24.8 to 26.3kg/m2 in women) also varied little. Distribution of other lipids, fibrinogen, exercise levels and fruit and vegetable consumption is also described. When district mean levels of major coronary risk factors are entered into predictive formulae, cigarette smoking and blood pressure could explain part of the regional variation in mortality, but much remains unaccounted for. Nonetheless, these levels provide data for local preventive initiatives. While the overall pattern and interaction of the factors will repay further study, the high levels of serum cholesterol in all districts, and the level and variation in cigarette smoking, are a challenge for action.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2631202     DOI: 10.1177/003693308903400604

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  25 in total

1.  Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factors.

Authors:  R W Morris; P H Whincup; F C Lampe; M Walker; S G Wannamethee; A G Shaper
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

2.  Problems in the interpretation of small area analysis of epidemiological data: the case of cancer incidence in the West of Scotland.

Authors:  D J Hole; D W Lamont
Journal:  J Epidemiol Community Health       Date:  1992-06       Impact factor: 3.710

3.  Exercise.

Authors:  H J Dargie; S Grant
Journal:  BMJ       Date:  1991-10-12

4.  Getting a handle on the prevalence of coronary heart disease.

Authors:  R J Simpson; A White
Journal:  Br Heart J       Date:  1990-11

Review 5.  Scottish hearts but British habits.

Authors:  H J Dargie
Journal:  BMJ       Date:  1989-12-16

6.  Prevalence of chronic cough and phlegm among male cigar and pipe smokers: results of the Scottish Heart Health Study.

Authors:  C A Brown; M Woodward; H Tunstall-Pedoe
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

7.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

8.  Vitamin E homologues α- and γ-tocopherol are not associated with bone turnover markers or bone mineral density in peri-menopausal and post-menopausal women.

Authors:  T C Yang; G G Duthie; L S Aucott; H M Macdonald
Journal:  Osteoporos Int       Date:  2016-05-02       Impact factor: 4.507

9.  Cigarette tar content and symptoms of chronic bronchitis: results of the Scottish Heart Health Study.

Authors:  C A Brown; I K Crombie; W C Smith; H Tunstall-Pedoe
Journal:  J Epidemiol Community Health       Date:  1991-12       Impact factor: 3.710

10.  Is the "Glasgow effect" of cigarette smoking explained by socio-economic status?: a multilevel analysis.

Authors:  Linsay Gray; Alastair H Leyland
Journal:  BMC Public Health       Date:  2009-07-17       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.